{[include file="_includes/_en/user_corp500_sub_js.html"]}

Zhejiang Vie Science & Technology Co., Ltd. Financial Data

Consolidated

Consolidated Balance Sheet (B/S)

(in million CNY)
  FY ended Mar. 31, 2018 FY ended Mar. 31, 2017 FY ended Mar. 31, 2016
Current assets 2,054.64 2,205.28 2,020.84
Illiquid assets 1,416.48 1,290.21 1,175.28
Total assets 3,471.12 3,495.49 3,196.12
Current liabilities 1,441.07 1,549.06 1,287.73
Illiquid debts 196.96 53.54 136.18
Total liabilities 1,638.03 1,602.60 1,423.90
Capital 479.65 479.65 479.65
Capital reserve 783.67 789.61 790.01
Profit reserve 72.26 70.70 63.24
Backlog profit 442.21 494.00 385.64
Minority stock holders' equity 55.31 58.93 53.69
Total stockholders' equity 1,833.09 1,892.89 1,772.22
Total Liabilities and shareholders' equity 3,471.12 3,495.49 3,196.12

 

Consolidated profit and loss statement

(in million CNY)
  FY ended Mar. 31, 2018 FY ended Mar. 31, 2017 FY ended Mar. 31, 2016
Sales 2,255.22 2,274.93 2,231.81
Operating profit (10.73) 170.18 154.42
Gross profit (11.99) 170.80 161.74
Net profit (34.89) 132.66 132.83



Consolidated Cash Flow

(in million CNY)
  FY ended Mar. 31, 2018 FY ended Mar. 31, 2017 FY ended Mar. 31, 2016
Cash flows from operating activities 235.13 159.26 131.20
Cash flows from investing activities (207.24) (207.59) (395.66)
Cash flows from financing activities (36.83) 80.97 521.88
Gains and losses from exchange-rate translation 2.17 (2.99) 1.25
Increases (decreases) in cash and cash equivalents (6.78) 29.65 258.67
Cash and cash equivalent at the beginning of the term 552.89 523.25 264.58
Cash and cash equivalents at the term-end 546.12 552.89 523.25

Non-consolidated

Unconsolidated Balance Sheet (B/S)

(in million CNY)
  FY ended Mar. 31, 2018 FY ended Mar. 31, 2017 FY ended Mar. 31, 2016
Current assets 1,210.96 1,196.69 899.16
Illiquid assets 1,450.11 1,381.50 1,345.42
Total Assets 2,661.07 2,578.20 1,345.42
Current liabilities 899.74 940.00 575.07
Illiquid debts 155.92 24.07 117.99
Total liabilities 1,055.66 964.08 693.06
Capital 479.65 479.65 479.65
Capital reserve 780.54 790.49 790.49
Profit reserve 49.75 48.18 40.72
Backlog profit 295.48 295.80 240.66
Total stockholders' equity 1,605.41 1,614.12 1,551.52
Total Liabilities and shareholders' equity 2,661.07 2,578.20 2,244.58

 

Unconsolidated profit and loss statement

(in million CNY)
  FY ended Mar. 31, 2018 FY ended Mar. 31, 2017 FY ended Mar. 31, 2016
Sales 1,212.22 1,170.02 814.27
Operating profit 34.99 96.18 79.09
Gross profit 34.86 96.69 83.47
Net profit 15.63 74.59 70.08

 

Unconsolidated cash flow

(in million CNY)
  FY ended Mar. 31, 2018 FY ended Mar. 31, 2017 FY ended Mar. 31, 2016
Cash flows from operating activities 133.22 75.33 81.43
Cash flows from investing activities (228.14) (98.11) (666.50)
Cash flows from investing activities 41.50 110.00 724.51
Gains and losses from exchange-rate translation 2.16 (2.66) 1.25
Increases (decreases) in cash and cash equivalents (51.27) 84.56 140.70
Cash and cash equivalent at the beginning of the term 380.95 296.39 155.69
Cash and cash equivalents at the term-end 329.69 380.95 296.39
Source : The Company's annual reports (data based on Chinese accounting standards)
Fiscal years ending in Dec. 31.